FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely oncourology. Determined root-mean-cube value of new growth by magnetic resonance tomography. Determined by immunoenzyme analysis of concentration of biomarkers in urine and blood serum – vascular endothelial growth factor (VEGF, in ng/ml), matrix metalloproteinaze 9 (MMP9, in ng/ml) and monocytic hemotoxic protein 1 (MCP1, in ng/ml). Then obtained values are introduced into the expressions C1-C6. Patient's kidney condition is estimated by maximum of the obtained values of C1-C6.
EFFECT: method allows for the rapid, high-tech, non-invasive way select from the group of urological patients with kidney cancer by evaluating the most significant parameters.
1 cl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR SCREENING PROBABILITY OF KIDNEY CANCER | 2023 |
|
RU2816798C1 |
| METHOD FOR DIAGNOSTICS OF HYPOXIA OF KIDNEY PARENCHYMA IN EXPERIMENTAL INTRAABDOMINAL HYPERTENSION | 2020 |
|
RU2749245C1 |
| METHOD OF DIAGNOSTICS OF KIDNEY DAMAGE IN CHILDREN WITH VESICOURETERAL REFLUX | 2023 |
|
RU2814399C1 |
| METHOD FOR DIAGNOSING BREAST CANCER AND OVARIAN CANCER BY MMP-9 MRNA LEVEL IN BLOOD PLASMA | 2020 |
|
RU2745424C1 |
| METHOD FOR PREDICTING RISK OF GRADE 3 MALIGNANCY OF TUMOR CELLS IN BREAST CANCER | 2023 |
|
RU2823459C1 |
| METHOD FOR PREDICTION OF RECURRENCES OF POSTOPERATIVE MENINGIOMAS | 2018 |
|
RU2689795C1 |
| METHOD FOR SPECIFYING LABORATORY DIAGNOSIS OF RENAL CELL CARCINOMA | 2021 |
|
RU2766295C2 |
| METHOD FOR DIAGNOSTICS OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS | 2017 |
|
RU2641964C1 |
| METHOD FOR INDICATING THE EFFECTIVENESS OF COMBINED ADAPTIVE STEREOTACTIC RADIOTHERAPY WITH BEVACIZUMAB IN MEN WITH MALIGNANT BRAIN GLIOMAS | 2023 |
|
RU2801419C1 |
| PREOPERATIVE DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR BONE TISSUE NEOPLASMS | 2014 |
|
RU2570748C1 |
